BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 18351300)

  • 1. Most pancreatic cancer resections are R1 resections.
    Esposito I; Kleeff J; Bergmann F; Reiser C; Herpel E; Friess H; Schirmacher P; Büchler MW
    Ann Surg Oncol; 2008 Jun; 15(6):1651-60. PubMed ID: 18351300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal adenocarcinoma of the pancreas treated with pancreaticoduodenectomy.
    Liszka Ł; Pajak J; Zielińska-Pajak E; Gołka D; Mrowiec S; Lampe P
    Pathology; 2010 Feb; 42(2):138-46. PubMed ID: 20085515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ductal adenocarcinoma of the head of the pancreas: a critical study of R1 resection rates].
    Delpero JR; Turrini O
    Bull Cancer; 2008 Dec; 95(12):1193-8. PubMed ID: 19091653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
    Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
    Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopically positive (R1) resections do not affect survival in pancreatic head cancer.
    Mois E; Graur F; Al-Hajjar N; Zaharie F; Bartos A; Bodea R; Zaharie T; Rusu I; Iancu C
    Ann Ital Chir; 2017; 88():491-496. PubMed ID: 29339587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining the R1 resection in pancreatic cancer.
    Verbeke CS; Leitch D; Menon KV; McMahon MJ; Guillou PJ; Anthoney A
    Br J Surg; 2006 Oct; 93(10):1232-7. PubMed ID: 16804874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.
    Van den Broeck A; Sergeant G; Ectors N; Van Steenbergen W; Aerts R; Topal B
    Eur J Surg Oncol; 2009 Jun; 35(6):600-4. PubMed ID: 19131205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgery for pancreatic cancer].
    Welsch T; Büchler MW; Schmidt J
    Z Gastroenterol; 2008 Dec; 46(12):1393-403. PubMed ID: 19053009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection margins and R1 rates in pancreatic cancer--are we there yet?
    Verbeke CS
    Histopathology; 2008 Jun; 52(7):787-96. PubMed ID: 18081813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins.
    Hernandez J; Mullinax J; Clark W; Toomey P; Villadolid D; Morton C; Ross S; Rosemurgy A
    Ann Surg; 2009 Jul; 250(1):76-80. PubMed ID: 19561479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
    Meriggi F; Gramigna P; Forni E
    Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.
    Kato K; Yamada S; Sugimoto H; Kanazumi N; Nomoto S; Takeda S; Kodera Y; Morita S; Nakao A
    Pancreas; 2009 Aug; 38(6):605-12. PubMed ID: 19629002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.
    Jamieson NB; Foulis AK; Oien KA; Going JJ; Glen P; Dickson EJ; Imrie CW; McKay CJ; Carter R
    Ann Surg; 2010 Jun; 251(6):1003-10. PubMed ID: 20485150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued.
    Mathur A; Ross SB; Luberice K; Kurian T; Vice M; Toomey P; Rosemurgy AS
    Am Surg; 2014 Apr; 80(4):353-60. PubMed ID: 24887665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer.
    Bilimoria KY; Talamonti MS; Sener SF; Bilimoria MM; Stewart AK; Winchester DP; Ko CY; Bentrem DJ
    J Am Coll Surg; 2008 Oct; 207(4):510-9. PubMed ID: 18926452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinical study about applying different R1 criteria to evaluate pancreatic head ductal adenocarcinoma specimens].
    Peng Y; Xiu D; Jiang B; Ma Z; Yuan C; Su J; Shi X; Li L; Tao M
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):834-8. PubMed ID: 25604022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.